Castle Bravo
Castle Bravo was the first in a series of high-yield thermonuclear weapon design tests conducted by the United States at Bikini Atoll, Marshall Islands, as part of "Operation Castle". Detonated on March 1, 1954, the device was the most powerful nuclear device detonated by the United States and its first lithium deuteride fueled thermonuclear weapon. Castle Bravo's yield was 15 megatons of TNT, 2.5 times the predicted 6.0 megatons, due to unforeseen additional reactions involving Li, which led to the unexpected radioactive contamination of areas to the east of Bikini Atoll.
Nuclear testing at Bikini Atoll
On the Marshall Islands, the detonation of Castle Bravo was the cause of most of the radiation exposure to the surrounding populations. The fallout levels attributed to the Castle Bravo test are the highest in history. The exposure to fallout has been linked to increase the likelihood of several types of cancer such as leukemia and thyroid cancer. The relationship between I-131 levels and thyroid cancer is continuing to be researched. There are also correlations between fallout exposure levels and diseases such as thyroid disease like hypothyroidism. Populations of the Marshall Islands that received significant exposure to radionuclides have a much greater risk of developing cancer. The Castle Bravo test detonation produced an explosion of approximately 15 megatons, which is about three times its predicted value. Populations neighboring the test site were exposed to high levels of radiation resulting in mild radiation sickness of many (nausea, vomiting, diarrhea). Several weeks later, many people began suffering from alopecia (hair loss) and skin lesions as well. The female population of the Marshall Islands have a sixty times greater cervical cancer mortality than a comparable mainland United States population. The Islands populations also have a five time greater likelihood of breast or gastrointestinal mortality, and lung cancer mortality is three times higher than the mainland population. The male population on the Marshall Islands lung cancer mortality is four times greater than the overall United States rates, and the oral cancer rates are ten times greater.